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2Summary
The HIV epidemic in Central Asia (Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and
Uzbekistan) started relatively recently but has dramatically accelerated since 2000. This
expansion in the epidemic is largely attributable to escalating injection drug use,
reflecting Central Asia’s geographic position on major drug trafficking routes. Although up
to 75% of cumulative HIV cases have been among injection drug users (IDU) to date,
HIV infections are increasing in other population groups, including female sex workers
and their clients, prisoners and migrants. Among IDU, risky injecting practices are highly
prevalent, whilst the intersecting epidemic of sexually transmitted infections, particularly
syphilis, highlights the potential for sexual transmission of HIV to bridging populations.
Few HIV cases in children have been reported to date, with most resulting from
nosocomial outbreaks in hospital settings. Some recent progress has been made towards
scaling-up prevention, treatment and care services, including harm reduction for IDU,
although key challenges remain.
3Introduction
The republics of Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and Uzbekistan
comprise the Central Asian sub-region, home to nearly 60 million ethnically
heterogeneous people, distributed across a geographic area of nearly 4 million km2
(Table 1). These five countries are classified as transitional economies by the World
Bank, with Kyrgyzstan, Tajikistan and Uzbekistan having Gross National Incomes below
US$650 per capita, less than 20% of their pre-independence levels(1).
The Central Asian Republics (CAR) have inherited Soviet health care infrastructures,
including vertical systems of care, which focus disproportionately on narrow provision of
specialized curative care for TB, sexually transmitted infections (STI) and drug use (1-3).
Transition (political, social and economic) since the early 1990s resulted in declining life
expectancies and re-emerging infectious diseases, including explosive syphilis outbreaks
(4-7), together with a weakening public health infrastructure (8;9). Ongoing health
reforms across Central Asia (CA) have focused on primary care and maternal and child
health (MCH), aiming to address the problems of fragmented primary care provision,
over-hospitalization and over-specialization (2;10). However, the infant mortality rate in
the CAR remains around 5-9 times higher than that in the European Union (Table 1)
(11).
Eastern Europe (EE) and CA together have one of the most rapidly accelerating HIV
epidemics worldwide (12), with recent exponential increases in HIV cases (Figure 1). Our
aim was to explore the published literature and provide a concise review of the current
HIV epidemic in CA and national responses, including HIV testing and prevention
activities, treatment and care.
Search strategy and selection criteria
A literature search was carried out using the PubMed and Web of Science databases, not
restricted to date but restricted to papers with English language abstracts. The keywords
4used in the search included “HIV”, “human immunodeficiency virus”, “AIDS”, “acquired
immune deficiency syndrome”, “Central Asia”, “Kazakhstan”, “Kyrgyzstan” “Uzbekistan”,
“Tajikistan”, “Turkmenistan”. Reference lists of relevant articles and reviews were
searched for relevant studies, as were the abstracts of recent conferences. Publications
and web pages of organizations such as WHO, UNAIDS, UNICEF, UNODC, the World
Bank, the Central Asia AIDS Control Project and the Eurasian Harm Reduction Network
were searched. This review makes little reference to the situation in Turkmenistan, where
there is only limited national data available. A recent report by Medecins Sans Frontieres
outlines the disincentives to reporting of data with respect to infectious diseases
including HIV (13).
Overview of HIV epidemic in Central Asia
Unfavorable socioeconomic conditions in CA, including increasing poverty, unemployment
and migration created the potential for a rapid increase in HIV infection driven by rising
numbers of injecting drug users (IDU), sex workers and high-risk sexual behaviors (4;5).
The evolution of and response to the HIV epidemic in CA needs to be considered in the
context of the overlapping epidemics of TB and STIs (4-7); syphilis prevalence in CA
reaches 2% in pregnant women and 40% in female sex workers (FSW), while TB
incidence is five to nine times higher than in the EU (14).
Although fast-growing HIV epidemics are in evidence across CA, Uzbekistan has the
largest number of HIV cases and is experiencing a particularly deteriorating situation
(Table 2). Newly diagnosed HIV cases increased more than 11-fold in Uzbekistan
between 2001 and 2006 compared with four-fold increases in Kyrgyzstan and Tajikistan
(15). Young people have been most affected by the HIV epidemic: in Uzbekistan 64% of
cumulative HIV cases have been among individuals aged ≤34 years, in Kyrgyzstan 57% 
of cases are in those aged <30 and in Kazakhstan 54% of cases are in the 20-29 year
age group (16;17). The predominant HIV genetic subtype in CA is subtype A, as found
5elsewhere in EE, distinguishing the epidemic in this sub-region from that in Western
Europe, where subtype B predominates (18-20).
National programmes for HIV/AIDS treatment and prevention have been established in
Kazakhstan, Kyrgyzstan, Tajikistan and Uzbekistan and all four countries have
successfully applied to the Global Fund for AIDS, TB and Malaria (GFATM) for grants to
finance scale-up of prevention, testing, treatment and care. The World Bank, bilateral
donors, UN agencies and other international organisations have provided considerable
financial and technical assistance in developing these programmes. Second generation
HIV sentinel surveillance has been ongoing in CA for several years, allowing accurate
data collection on the epidemic (17, 21-29). Such data are essential for programme
development and evaluation, but this is hindered by uncertainty regarding the size of
most-at-risk populations across CA.
Epidemiology: HIV prevalence and risk factors among at risk populations
Injecting drug use
CA is experiencing substantial increases in both trafficking and use of illicit drugs, driven
by its geographic position on drug-trafficking routes from Afghanistan, domestic opium
production in the south of the sub-region and prevailing socio-economic conditions
(1;9;30-32). Although injection of heroin or home-made opiates (e.g. “khanka”)
predominates, stimulant injection has also substantially increased, with 69% of IDU in
one Kazakhstan study reporting methamphetamine use (33). Injecting drug use has
driven the HIV epidemic in CA to date, accounting for 50-70% of cumulative HIV cases.
Reported HIV cases among IDU increased substantially between 2002 and 2006, with
increases of 482% in Tajikistan, 130% in Uzbekistan, 132% in Kazakhstan and 30% in
Kyrgyzstan (34) and HIV prevalence among IDU is increasing across the sub-region (17).
However, HIV surveillance among IDU is subject to selection bias, often focusing on
registered IDU who have longer injecting histories and/or are more likely to be in contact
with services (21). Sentinel surveillance data indicate HIV prevalence of around 7%
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in Kazakhstan and 16% in Uzbekistan and Tajikistan overall (21), but outbreaks of HIV
among IDU in specific cities have recently been reported, resulting in considerably higher
prevalence (Table 3); e.g. in Dushanbe, HIV prevalence increased from 3.9% in 2001 to
12% in 2004 and 24% in 2006 (Table 3), while in Karaganda, Kazakhstan, HIV
prevalence has reached 19% (17). Dramatic and rapid increases in HIV infections have
recently been reported in Western Siberia, in the Russian Federation, with increases of
up to 700% mostly among IDU (35); increasing HIV prevalence has also been reported
among IDUs living in Kazakhstan along the Russian border (35).
The rapid spread of HIV among IDU in CA has been facilitated by high prevalence of risky
behaviours; 50-70% share injecting equipment, purchase pre-filled syringes or draw-up
from common containers, while condom use is low (1;21;23;36-39) (Table 4). Specific
drug preparation practices may also potentially increase risk, with blood used in the
preparation of “vtoryak”, a solution obtained by reprocessing materials after preparation
of “khanka”; however, “vtoryak” was used by less than half of IDUs in a 2002 study in
Kazakhstan (26). Studies have demonstrated average durations of injecting of 3-9 years
among IDU, the average age of whom is decreasing (23;39-41). In Tajikistan, recent
initiates were twice as likely to be HIV-infected as those with longer injecting histories,
suggesting riskier HIV behaviours (42) and potentially less use of harm reduction
services than older, more established IDU. Prevalence of HCV and of syphilis among IDU
can indicate the extent of risky injecting and sexual behaviours respectively. HCV
prevalence among IDU exceeds 60% in Tajikistan and Uzbekistan and 70% in parts of
Kazakhstan, and up to one in six IDU have syphilis (17;39;43) (Table 3). Female IDU are
particularly vulnerable to acquisition of HIV, HCV and STIs, due to exchange of sex for
drugs or money and risky injecting behaviours (36;44): 28% of female IDU in a study in
Dushanbe, Tajikistan had syphilis (75% of whom reported transactional sex) compared
with 13% of males (39), while in a study in Kazakhstan, female IDU were 2.3 times more
likely to be HIV-positive than males and had a syphilis prevalence of 11% compared with
75% among male IDU (26), The estimated 20-24% of male IDU who have sex with FSW
also underscores how these risk groups intersect (21;40;41;45).
Sex work
The size of the sex worker population in CA is difficult to estimate, reflecting the illegal
and often temporary nature of sex work. In Kazakhstan, 1-4 per 1000 residents in major
cities are estimated to engage in sex work, with estimates of 8 per 1000 in Dushanbe
and 2-3 per 1000 in Tashkent (46). As little is known about male sex work in CA, this
section will focus on FSW and their clients. FSW tend to be young (average <25 years),
single and are often highly mobile, which may contribute to HIV spread (36). At least 10-
30% of FSW are thought to inject drugs and around 50-65% of female IDU across the
sub-region are estimated to exchange sex for drugs or money (21;23;40;41). Overall,
HIV prevalence among FSW is around 2% in CA (Figure 2), although among FSW who
inject drugs, prevalence is at least five- to six-fold higher (21;27;28). High syphilis
prevalence among FSW, at between 15-40%, highlights their increased risk for both HIV
acquisition and transmission (21;27;38;47). In one study of FSW in Tashkent (Table 3),
53% of those HIV-infected were IDU (45) and second generation surveillance
demonstrated substantially higher HIV prevalence among FSW who injected drugs
compared with those who did not inject, e.g. 14% versus 2% in Kazakhstan and 31%
versus 5% in Uzbekistan (17). Surveillance has also demonstrated substantially higher
syphilis prevalence among FSW who inject drugs, e.g. 42% versus 25% in Uzbekistan
(17), suggesting that this sub-group of FSW are also at greater risk of sexual acquisition
of HIV.
FSW clients are generally married or cohabiting, for example, two-thirds had long-term
partners in studies in Kyrgyzstan and Kazakhstan (40;41). Three-quarters of FSW clients
in a study in Karaganda, Kazakhstan had at least four new sex partners in the previous
12 months, indicating the importance of this group as a bridging population, particularly
as they are at risk of concurrent STI infections (40;41). A survey of 600 students in
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high proportion given their young age (median 20 years) (48).UNAIDS estimates that
one in eight to nine HIV cases in EE and CA are among sex workers and their clients
(38).
Migrant workers
Migrants can link low and high prevalence populations, “seed” new outbreaks, may
engage in risky behaviours (49), and appear to play a key role in the spread of HIV in EE
& CA (50). There is a growing reliance on migration for employment in parts of CA, with
large numbers of labour migrants travelling to Kazakhstan and the Russian Federation
(1;21). Around 600,000 to 1 million workers in Tajikistan, 300,000-500,000 in
Kyrgyzstan and 330,000 in Uzbekistan are estimated to work abroad (1;36;51). Most
migrant workers are male, but increasing numbers of women are participating in labour
migration. Sex trafficking of women from and within CA is also a growing problem
(52;53). A study of 30 Tajik male migrant workers in Moscow found that all had regular
sex with FSW, rarely with condoms, returning home to their wives for several months
each year (51). In a study in Tajikistan, IDU who had worked abroad were 2.5-times
more likely to be HCV-positive than other IDU, suggesting risky injecting behaviour (39).
In Kazakhstan, there was an approximate 30% increase in HIV cases among non-
nationals between 2005 and 2006, while in Tajikistan around half of all registered HIV
cases have been among labour migrants (21).
Men who have sex with men (MSM)
MSM are a marginalized group in CA, hard-to-reach for surveillance and prevention.
Homosexuality is criminalized in Uzbekistan and Turkmenistan (54) and generally in CA
MSM face considerable stigma and discrimination (1;21). Sentinel surveillance among
MSM has been based on small numbers to date and prevalence estimates should be
interpreted with caution (Figure 2). Syphilis prevalence of 23% has been reported among
9MSM in Kyrgyzstan, while in Uzbekistan, surveys among MSM have indicated that 39%
do not use condoms with non-regular male partners (38).
Prison populations
HIV testing within prison populations has been widespread in CA, reflecting sentinel
surveillance and mandatory testing policies. HIV prevalence among prisoners ranges
from 2% in Kazakhstan to nearly 7% in Tajikistan (Figure 2). By the start of 2007, >25%
of cumulative registered HIV cases in Kazakhstan were in prisoners, while in Tajikistan, a
fifth of the registered HIV population are prisoners (21;50); these proportions reflect HIV
testing policies, criminalization of illicit drug use and high rates of risk behaviours among
prisoners, both inside and outside prison settings (44). In CA, 5-25% of prisoners are
estimated to have drug dependence (33) and up to 70% share injecting equipment
(21;55). In one study in Kazakhstan, the prevalence of syphilis among prisoners in
temporary detention was 5% (25). TB prevalence among inmates is 60-100 times higher
compared to the general population, with high TB mortality (50) .
Women, mother-to-child HIV transmission and pediatric AIDS
Women
Around one in three registered HIV cases are female in Uzbekistan and Kazakhstan,
decreasing to one in four in Tajikistan and Kyrgyzstan (Table 2). Disaggregated data by
sex and risk group are lacking, but around 15% of IDU in CA are female (33) and it is
likely that across the sub-region most HIV-positive women to date have injecting drug
use-related acquisition, either their own or that of their partners. In Kyrgyzstan, 66% of
HIV-positive women have reported sexual acquisition of infection (21). However,
classification of HIV cases by transmission route can be difficult, as injecting drug use is
frequently under-reported. Studies in the Russian Federation have demonstrated that at
least 25% of women reporting sexual acquisition of HIV were HCV-positive, suggesting
an injecting drug use history (35), while second generation surveillance in Kazakhstan
indicated that 27% of FSW were HCV positive but only 10% reported injecting drug use
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(29). Heterosexual transmission of HIV is increasing (21), now accounting for 19-26% of
cumulative HIV reports, with a concomitant rise in female cases; e.g. in Uzbekistan the
proportion of female HIV cases increased from 10% in 2001 to 34% in 2007 (16). IDU in
CA are sexually active, have high sexual partnership rates, high rates of STI coinfection
and low rates of consistent condom use (17;23;40;41). These factors can all facilitate
heterosexual spread of HIV and having an IDU sexual partner is one of the main risk
factors identified among newly diagnosed HIV-infected women, together with having a
partner who is an ex-prisoner or a migrant worker, consistent with the evolution of the
epidemic in EE (56).
Children
By the end of 2006, 94 vertically-infected children had been reported from Kazakhstan,
Kyrgyzstan, Tajikistan and Uzbekistan (15). However, most HIV-infected children
diagnosed to date in CA were infected nosocomially. Major outbreaks of hospital-acquired
HIV infection were reported in Shymkent, Kazakhstan and Osh, Kyrgyzstan in 2006 and
2007 respectively (57;58), with another subsequently identified in Uzbekistan, in Andijan
and Namangan in the Ferghana Valley (59). Of note, these outbreaks occurred in
hospitals situated on major drug trafficking routes from Afghanistan. Investigation of the
first two outbreaks by the national authorities in collaboration with the USA Centers for
Disease Control and Prevention (CDC) CA regional office identified a combination of
factors including poor blood safety, unsafe injections and lack of adequate sterilization
procedures as likely causes, whilst prolonged hospitalizations extended exposures. A
previous WHO-led assessment of paediatric hospital care in Kazakhstan identified high
rates of lengthy and unnecessary hospitalisations and widespread yet avoidable
administration of drugs by injection (60). Substantial anecdotal reporting of inadequate
supplies of disposable equipment including needles and syringes across CA has been
confirmed in Kyrgyzstan following a recent situation analysis which identified chronic
shortages of such commodities (61). The number of children with hospital-acquired HIV
infection in CA is uncertain, as investigations in some countries are ongoing and there
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are disincentives to publish these data. In Kyrgyzstan 164 cases had been officially
reported by mid 2009 (62), in Kazakhstan, 118 cases were reported between May 2006
and June 2007 (63) and in Uzbekistan 147 cases in the Namangan outbreak had been
reported by March 2010 (64).
Most-at-risk adolescents and young people
Approximately one third of new HIV infections in EE and CA are among 15-24 year olds
(12) and there were an estimated 340,000 young people aged 15-24 living with HIV in
the Region in 2007 (65). Data on the numbers of youth engaged in drug use, sex work
and young MSM are extremely scarce. A survey in Uzbekistan among adolescents (aged
10-18), who injected drugs, sold sex and engaged in male-to-male sex, showed that
66% lacked basic knowledge of HIV prevention and skills to protect their own health
(66). No data are published on HIV prevalence among street children in CA, but a
prevalence of 37% was reported in St. Petersburg, Russian Federation (67), indicating
extremely high vulnerability of this population to HIV.
HIV testing
Funding through GFATM grants to Kazakhstan, Kyrgyzstan, Tajikistan and Uzbekistan
have helped to facilitate the scale-up of HIV testing programmes in CA. In Kazakhstan
and Tajikistan the number of health facilities providing HIV testing and counselling
increased by 50-100% between 2007 and 2008, with 3,000 adults covered by each
testing facility in Kazakhstan, which has the highest rate of HIV testing in the European
Region, at 119.1 per 1000 (68); in contrast there are >100,000 adults per facility in
Kyrgyzstan (69). Mandatory HIV testing of some groups continues to occur in CA,
including detained FSW and prisoners; in a Kyrgyzstan study of FSW, among those
recently tested, half had received a compulsory test (41). Networks of “Trust Points”
have been established across CA where individuals can access voluntary counselling and
testing (VCT) anonymously, although the fact that these are largely government-run may
prevent some individuals, especially FSW or IDU, from seeking testing. HIV testing can
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also be accessed at HIV/AIDS Centres and in antenatal care settings. Coverage of FSW
with a recent HIV test (within past 12 months) is estimated to be high in Kazakhstan and
Kyrgyzstan (70% and 53% respectively), partly due to compulsory testing, and is 29% in
Tajikistan and 19% in Uzbekistan (12). Coverage of IDU with a recent HIV test is lower
than among FSWs, ranging from 42% in Kazakhstan to 18% in Uzbekistan (Table 4)
(12). In the general population, coverage with HIV testing is <5% (12), and specific
groups such as labour migrants working illegally are likely to have very low coverage,
reflecting difficulties accessing health care (70). Point-of-care HIV testing is carried out
in the context of PMTCT in Kazakhstan and Kyrgyzstan, mainly rapid HIV testing in labour
of women with undocumented HIV status, although there is some use of rapid tests in
antenatal care settings as well.
Treatment and care
HIV/AIDS services throughout CA are organised through a network of Republican and
regional HIV/AIDS Centres, with a similarly vertical approach for drug addiction, STIs and
TB services. The weak functional linkages between HIV/AIDS Centres and these other
service providers (e.g. TB Institutes and Narcology (Addiction Service) Centres) is a key
barrier to provision of comprehensive care to PLHIV (50). Specific experience relating to
antiretroviral therapy (ART) is usually limited to HIV/AIDS Centres, with restricted
knowledge of HIV treatment elsewhere. Estimates derived from epidemiological
modelling indicated that <25% of adults and children with advanced HIV disease in CA
received ART in 2007 (12);(69). There is wide variation in laboratory capacity for
diagnosis and monitoring of HIV infection in CA. Kazakhstan has achieved the highest
capacity, including DNA PCR testing for early infant diagnosis and CD4 count monitoring,
with high coverage achieved (Table 5). However, limited laboratory capacity exists
elsewhere, for example, with CD4 count facilities available in only two districts in
Tajikistan.
Prevention
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Primary prevention
With financial support from national GFATM grants and cooperation from international
organizations, prevention efforts are scaling-up across CA, largely concentrating on IDU
and FSW to date. Harm reduction efforts for IDU have been impeded by a lack of strong
political support and legislative barriers, including punitive laws regarding drug use and
hard-line policing (23-25). However, Kyrgyzstan has achieved substantial progress in
harm reduction, reflecting the explicit political support received and removal of some
legal barriers (24;33). Some CA countries have achieved medium coverage of IDU with
low threshold services, mainly through Trust Points and outreach; for example, coverage
has reached 61% in Kyrgyzstan and around 35% in Kazakhstan and services include
provision of clean needles/syringes and condoms and VCT or referral for HIV testing.
However, coverage with needle and syringe exchange programmes (NEP) and opioid
substitution therapy (OST) remains sub-optimal in CA (71) (Table 4). Efforts are ongoing
to scale-up harm reduction activities and Kazakhstan now has a pilot OST programme,
with a pilot planned in Tajikistan, although the pilot in Uzbekistan was recently closed by
the government (24). In Kyrgyzstan, OST has been available since 2002 and recently
became available to prisoners, along with NEP (33). A recent study indicated that
awareness of HIV services among IDU is highest in Kyrgyzstan at 70%, is around 50% in
Kazakhstan and <10% in Tajikistan (23).
Trust Points across CA provide targeted prevention services for FSW. Higher rates of
condom use among FSW and their clients (80-90% with last new partner) compared with
other respondents in studies in Kyrgyzstan and Kazakhstan suggest that some prevention
messages are reaching these groups; however, only 60% used condoms consistently
(27;36;40;41;72-74). In a Tashkent study, 31% of FSW used condoms consistently with
clients, but only 11% of those married or cohabiting did so with their regular partners
(27;36;72-74). Prevention activities have focused on FSW and not their clients, despite
their potential for introducing HIV into the general population. In particular, migrant
workers should be targeted, as many have contact with the lowest stratum of sex
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workers, who have the highest HIV risk (52), yet have limited HIV awareness, with no or
rare condom use (51). Media campaigns raising HIV prevention awareness directed at
labour migrants are ongoing in Tajikistan.
In CA, barriers preventing vulnerable groups from accessing harm reduction services
include the legislative environment (including criminalization of sex work and
homosexuality), stigma and discrimination and access issues (coverage, geographic
barriers) (9;23;36;75;76). These barriers are likely to contribute to ongoing high risk
behaviours. In particular, coverage of most-at-risk adolescents and young people with
prevention services is considerably lower than for older most-at-risk populations. The
most recent DHS in Kazakhstan indicated that 10% of married men had extramarital sex
with at least one woman during the past 12 months, increasing to 22% of those aged 20-
24 years; condom use at most recent intercourse with non-cohabiting partners was
nearly 60% among men (77). Culture and traditions can impede open discussion of
issues relating to sexual practices, and may present obstacles to sensitising communities
and increasing awareness of HIV.Targeting unmarried youth, particularly women, with
sex education may be problematic in CA (78), which may partly explain current low
levels of adequate knowledge of HIV transmission and prevention among youth (Figure
3). In Kazakhstan, 96% of pregnant women had heard of HIV/AIDS, but knowledge
tended to be superficial and 42% reported having insufficient prevention information;
36% of Kazakh women reported adequate knowledge compared with 63% of ethnic
Russians (79).
Prevention of infections in infants
All CA countries have endorsed the European Region goal of eliminating HIV infection in
infants (i.e. reducing MTCT rates to 2%) by 2010 (80). Estimates of HIV prevalence
among pregnant women range from 0.5 to 7 per 1000 (Figure 2) (21;22). Numbers of
registered HIV-infected pregnant women are increasing annually across CA, reflecting
both transmission patterns and improved ascertainment. Nonetheless, official numbers of
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pregnant HIV-infected women are likely to be underestimates, particularly where
antenatal testing is limited to selected groups (Table 5). Progress in PMTCT has occurred
across CA but has been particularly noteworthy in Kazakhstan, where high coverage with
antenatal HIV testing and with PMTCT prophylaxis has been achieved, indicating good
linkages with MCH services (12) (Table 5).
Blood safety
The World Bank recently investigated blood services in CA and identified patchy and poor
quality screening, including undetected cases of HIV (prevalence of 0.2%)(81). The
report highlighted fragmented and under-resourced services, lacking national
coordination; other systemic deficiencies included use of glass bottles, use of paid and
replacement donors and lack of supplies. The existence of illegal trade in donor blood,
incentivizing unnecessary blood transfusions, was highlighted in the trials of Kazak
medical workers in 2007 following hospital-based HIV outbreaks among children (82);
blood transfusion services have since been upgraded. Some initial measures have also
been implemented by the other countries (83).
Viewpoint on national responses to HIV in Central Asia: the case of PMTCT and
paediatric HIV/AIDS as an entry point for health systems’ strengthening
Prompt identification of HIV-infected pregnant women and children, with provision of
effective PMTCT interventions and HIV treatment, are global priorities and central to the
aim of moving towards an HIV-free future generation (84). Important progress in PMTCT
has been achieved in practically all CA countries although there are some key challenges
remaining, in particular on issues of quality of care. The barriers limiting progress in the
implementation of HIV prevention and treatment in CA can be clearly illustrated by
national responses to PMTCT and paediatric HIV/AIDS. The vertical care system is a key
barrier to progress, with no or weak coordination between HIV/AIDS care providers and
other services which may identify and/or provide services to HIV-infected women and
children, including antenatal/maternity care, reproductive health, primary care and
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narcology (addiction) services. There is also a lack of cross-referrals and functional
linkages across service providers, including between the health and broader social
services, and insufficient coordination between ongoing initiatives, including between
paediatric AIDS treatment and Integrated Management of Childhood Infections (84).
However, in Kazakhstan recent collaboration between the Safe Motherhood and PMTCT
has had good results.
The nosocomial HIV “outbreaks” among children in Kazakhstan, Kyrgyzstan and
Uzbekistan, with at least 400 infected children identified to date, have demonstrated
structural and systemic weaknesses of health care systems, including fragmented service
delivery, limited resources, interrupted medical supplies, outdated infection control and
blood use protocols, flawed blood management systems and limited staff capacities
(59;81;82). Ongoing responses have focused on implementing specific measures to
address these weaknesses. However, the punitive nature of the system in CA,
exemplified by the conviction and imprisonment of health care workers following the
nosocomial outbreaks (63), generates distrust and hinders constructive approaches to
change.
The relatively sudden emergence of a sizable population of HIV-infected children meant
that there was an initial lack of preparedness and limited capacity for paediatric HIV care
and treatment, although subsequently large-scale trainings, clinical mentoring and
establishment of pools of regional expertise took place, which will benefit the system
overall. The response has boosted governmental commitment to scaling-up paediatric
HIV treatment and care in CA, although national scale-up plans have not yet been
formalized. All countries will benefit from technical assistance with regard to specific
aspects of increasing treatment access, including programme development and effective
supply management, and are receiving an external support with this from UN agencies
and other international organizations. Work by national and international organizations
with families affected by HIV/AIDS has enabled a much needed strengthening of
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community involvement. Emergence of parent support groups, advocating for infected
children’s rights to treatment, care and education has been an important catalyst in the
emergence of civil society organizations addressing HIV.
Conclusions
In CA, HIV prevalence has reached concerningly high levels among IDU, reaching 25-
30% in some cities, and up to 30% among FSW who inject drugs. Recent surveillance
has identified very high levels of risky injecting behaviour and the continued expansion of
the HIV epidemic among and beyond the IDU population demonstrates that harm
reduction services have not achieved the coverage necessary to stabilize HIV spread.
Furthermore, in Uzbekistan there has been reversal of policies on harm reduction and
OST, highlighting the relative fragility of some achievements made. The increasing HIV
infections among women who do not inject drugs themselves highlights how a large and
growing HIV epidemic among IDU has the potential to fuel heterosexual transmission, as
has been the case in parts of EE. Considerable scope for continued expansion of the HIV
epidemic is provided by sexual mixing between populations at higher and lower risk, high
STI coinfection rates and low consistent condom use, with labour migration another key
driver Improving coverage of IDU, FSW and clients and migrants with prevention services
should be a key priority, including addressing current legislative barriers to access, but is
impeded by the stigma around behaviours linked with HIV and by a lack of strong
political commitment towards serving the needs of these populations.
There is heterogeneity within the sub-region regarding capacity for HIV diagnostics,
treatment, prevention and care. Kyrgyzstan is recognized as having led the way with
harm reduction for IDU, with evidence of a slowing of the spread of HIV among IDU
compared with other countries in CA. Kazakhstan has good capacity for surveillance,
diagnostics and treatment, reflecting its relative wealth and economic growth, but this
means that it is not eligible to apply further to GFATM. Important failures in the health
system and the need for restructuring and investment in health care systems have been
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exposed by the nosocomial spread of HIV in CA. Development and implementation of HIV
prevention programmes in general should be seen as an opportunity to enhance ongoing
health care reforms and strengthen the prevention, care, support and protection systems
with a view towards addressing the needs of the affected populations. However, the
vertical systems of care, insufficient linkages between services, limited capacity and
inadequate resources are barriers to scaling-up a multi-sectoral response to the HIV
epidemic. Stigma and discrimination around HIV remains a key challenge, although the
growing civil society movement should help to engender change.
Much of the data presented in this review were officially reported by the governments of
the CAR, for example through UNAIDS reporting exercises. Difficulties in estimating the
size of HIV epidemics in countries with concentrated epidemics are well recognized (85),
and are likely to be compounded in CA where there remains tight governmental control
regarding national data reporting and dissemination and where there has been a very
recent acceleration in the HIV epidemic, such as in Uzbekistan. Although second-
generation surveillance is ongoing, limitations include a lack of accurate estimates of the
size of most-at-risk populations. It is therefore likely that the data presented here
considerably under-estimate the actual magnitude of the HIV epidemic in CA and provide
an incomplete picture of the current situation. However, it is clear that there is an urgent
need to implement effective HIV prevention measures in CA, which will require robust
and consistent national political support.
19
Table 1 Socio-demographic, economic and health indicators, Central Asian Republics
Indicator Kazakhstan Kyrgyzstan Tajikistan Turkmenistan Uzbekistan
Population size 15.3m 5.26m 6.64m 4.90m 27.0m
Annual births 289 000 113 000 185 000 108 000 619 000
Total fertility rate 2.2 2.5 3.5 2.6 2.6
Infant mortality rate per
1000 livebirths
62-63 58-61 91 74-80 57-62
Life expectancy at birth
(yrs)
66 66 66 63 67
Population annual
growth rate (1990-
2006)
-0.5% 1.1% 1.4% 1.8% 1.7%
Human Development
Index ranking
73 116 122 109 113
GNI per capita (US$) 3790 490 390 1 340 610
Total health expenditure
as % of GDP (2005) 3.9% 6.0% 5.0% 4.8% 5.0%
% population urbanized 58% 36% 25% 47% 37%
Antenatal care coverage 100% 97% 77% 99% 99%
% births with skilled
attendant
100% 98% 83% 100% 100%
Life-time risk of
maternal death
1 in 360 1 in 240 1 in 160 1 in 290 1 in 1400
(11;77;86-88)
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Table 2 The HIV epidemic in Central Asia – key data
Kazakhstan Kyrgyzstan Tajikistan Turkmenistan Uzbekistan
Estimated
adult HIV
prevalence
(%) (2007)
0.1% 0.1% 0.3% <0.1% 0.1-0.2%
UNAIDS
estimate of
number of
PLHIV
(2007)
12,000 4,200 10,000 <500 16,000
Estimated
cumulative
number of
PLHIV
(start 2009)
14,200 4,200 8,000 <500 16,000
HIV cases
officially
reported in
2007
1,979 409 339 N/A 3,169
Number
PLHIV
enrolled in
HIV care
7575 840 995 N/A N/A
% HIV
cases
female
(2007)
30% ~25% 24% N/A 34%
Prevalence
of injecting
drug use
1-3% 0.5-1.5% N/A
[(11;12;32;68;89)]
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Table 3
HIV prevalence from selected studies among IDU and FSW
Study details Setting HIV
prevalence
Other details Ref
Cross-sectional survey of
community recruited IDU,
2003-2004 (n=701)
Tashkent,
Uzbekistan
29.8% 5% female (90)
Community-recruited IDUs
(injected within past month),
May – November 2004
(n=491)
Dushanbe,
Tajikistan
12.1%
overall, 19%
amongst
ethnic Tajiks
15% female;
61.3% HCV
positive; 16%
had syphilis
(42)
Unlinked anonymous
seroprevalence survey, 2006
(n=400)
Dushanbe,
Tajikistan
24% (34)
Cross-sectional survey of IDU,
Respondent-driven sampling:
34% syringe exchange
programme clients, 66%
community-recruited by
clients; 2002 (n=1799)
Temirtau &
Karaganda,
Kazakhstan
24.7%
(18.8%)* in
Temirtau and
2.3%
(1.2%)* in
Karaganda
25% female;
85% and 74%
HCV positive in
Temirtau &
Karaganda
respectively;
6.5% had
syphilis
(26)
Cross-sectional study of FSW
with outreach worker
recruitment, 2003-2004
(n=448)
Tashkent,
Uzbekistan
10.0% 9.2% also IDU (45;73)
* estimates adjusted for sample selection process
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Table 4
Risk behaviours among IDU and coverage of harm reduction programmes
% reporting use
of sterile
injecting
equipment at
last injection1
% reporting
condom use at
last sexual
contact1
% sharing
syringe at last
injection
Number NEP
per 1000
IDUs1
OST sites
per 1000
IDU1
% IDU reached
with HIV
prevention
programmes in
past 12 months
% IDU who
received HIV
test and
results in past
12 months4
Kazakhstan 60% 42% 20%2 1.2 0 47%1 42%
Kyrgyzstan 23% 27% 21%3 2.0 0.7 - 34%
Tajikistan 63% 39% - 1.2 - 25%4 24%
Uzbekistan 84% 36% - 7.0 6.75 40%1 18%
NEP: Needle and syringe exchange programme; OST: oral substitution therapy
1 2006-2008 data (69)
2 2003 data (40)
3 2003 data (41)
4 2007 data (12)
5 OST is no longer available in Uzbekistan
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Table 5
Prevention of mother-to-child transmission services in Central Asia
Components of PMTCT
programme
Current situation
Antenatal screening
Policies
 Kazakhstan & Kyrgyzstan: routine provider-initiated testing for all women,
provided on an opt-out basis
 Turkmenistan: mandatory testing
 Uzbekistan: selective opt-out, but routine for all women in some areas
 Tajikistan: selective opt-in, but routine for all women in high prevalence areas
Coverage
 >95% in Kazakhstan and Kyrgyzstan, 78% in Uzbekistan and 21% in
Tajikistan
Antiretroviral prophylaxis for
PMTCT
UNAIDS low to high estimates of % coverage of HIV-positive pregnant women
 Kazakhstan: >95%
 Kyrgyzstan: 2 – 8%
 Tajikistan: 5 – 19%
 Uzbekistan: 17 – 74%
UNICEF coverage figures: antenatal and/or neonatal prophylaxis
 Kazakhstan: 88% antenatal, 95% neonatal
 Kyrgyzstan: 5% antenatal, 6% neonatal
 Tajikistan : 52%
 Uzbekistan: 69%
 Centralisation of antiretroviral prophylaxis provision at HIV/AIDS Centres
 No or restricted provision for antiretroviral supply at maternity hospitals
 Triple-drug prophylaxis from 24 weeks used in Kazakhstan
 Prophylaxis mainly based on single dose nevirapine and/or short-course
zidovudine elsewhere, although with some triple-drug use in Uzbekistan
ART for women requiring
treatment
 96% of HIV-infected pregnant women were assessed for ART eligibility in
Kazakhstan (CD4 count and clinical assessments)
Early diagnosis of infants
born to HIV-positive mothers
 In Kazakhstan, 4 laboratories have the capacity for PCR testing for infant
diagnosis and in 2008 95% infants born to infected mothers received a
virological test within two months of birth
24
 Limited PCR facilities/laboratory staff capacity in Uzbekistan and Tajikistan, and
one laboratory in Turkmenistan
(UNICEF report card data, 2007, 2008; (12))
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Figure 1
New HIV infections (rates per million population) by country and year of report
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Figure 2
HIV infection prevalence according to sentinel epidemiological surveillance surveys, 2007
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Figure 3
Percentage of young women and men (15-24 years) who both correctly identify
ways of preventing the sexual transmission of HIV and who reject major
misconceptions regarding HIV transmission (UNGASS indicator 13) (12)
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